Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolus, Inc.EOLS · Entity 5341 | Director | March 07, 2025 | March 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolus, Inc.
Report date March 07, 2025 · Filed March 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,111 |
Reported balance
After 2025-03-07 transaction · row 1
1 source rowRow 1 · 2025-03-07 · Grant · Acquired 7,364 · Balance 77,111 F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.58 · Expires 2035-03-07 | Direct | 11,146 |
Reported balance
After 2025-03-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-07 · Grant · Acquired 11,146 · Balance 11,146 F3: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 482,783 |
Reported balance
Holding disclosure · report date 2025-03-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 482,783 F2: Represents shares held by Dental Innovations Apus Investment BV ("DIAI") and may be deemed beneficially owned by the Reporting Person as the sole beneficial owner of DIAI. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
F2: Represents shares held by Dental Innovations Apus Investment BV ("DIAI") and may be deemed beneficially owned by the Reporting Person as the sole beneficial owner of DIAI.
F3: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2025 Filed Mar 11, 2025 18:54 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 11,146 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0001570562-25-000040 · wk-form4_1741733653.xml · derivative · entry 3 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,146 Underlying: Common Stock · 11,146 shares Expires 2035-03-07 F3 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:54 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 7,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-25-000040 · wk-form4_1741733653.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,111 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 18:38 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 9,377 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001570562-24-000025 · wk-form4_1707521878.xml · derivative · entry 3 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,377 Underlying: Common Stock · 9,377 shares Expires 2034-02-07 F3 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 18:38 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 6,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-24-000025 · wk-form4_1707521878.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,747 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 7, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 16:32 UTC | Evolus, Inc. EOLS · Entity 5341 | OtherCommon Stock | 115,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-23-000092 · wk-form4_1692131560.xml · nonDerivative · entry 2 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 482,783 F1 · kind: Pro rata distribution from Alphaeon 1, LLC of which the reporting person is a non-managing member. F2 · ownership.nature: Represents shares held by Dental Innovations Apus Investment BV ("DIAI") and may be deemed beneficially owned by the Reporting Person as the sole beneficial owner of DIAI. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 16:32 UTC | Evolus, Inc. EOLS · Entity 5341 | OtherCommon Stock | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-23-000092 · wk-form4_1692131560.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,283 F1 · kind: Pro rata distribution from Alphaeon 1, LLC of which the reporting person is a non-managing member. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 20:41 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 11,789 | $0.00 Strike: $10.25 | $0.00 |
DisclosureSEC source: 0001570562-23-000022 · wf-form4_167521567128262.xml · derivative · entry 3 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,789 Underlying: Common Stock · 11,789 shares Expires 2033-01-27 F3 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 20:41 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 8,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-23-000022 · wf-form4_167521567128262.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,174 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 09:29 UTC | Evolus, Inc. EOLS · Entity 5341 | PurchaseCommon Stock | 20,000 | $9.24 | $184,844.00 |
DisclosureSEC source: 0001570562-22-000128 · wf-form4_166264373900205.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,881 F1 · price: The shares were purchased in multiple trades at prices ranging from $9.08 to $9.52. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Total includes 15,568 shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:00 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 22,727 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001570562-22-000046 · wf-form4_164324881157044.xml · derivative · entry 2 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock · 22,727 shares Expires 2032-01-24 F2 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:00 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 15,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-22-000046 · wf-form4_164324881157044.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,881 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer Read SEC document |
| February 05, 2021 Filed Feb 12, 2021 18:24 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 19,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-21-000045 · wf-form4_161317226111527.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,313 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 5, 2021, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 21:14 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 23,458 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0001570562-20-000046 · wf-form4_157991842431171.xml · derivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,458 Underlying: Common Stock · 23,458 shares Expires 2030-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| May 20, 2019 Filed May 22, 2019 19:12 UTC | Evolus, Inc. EOLS · Entity 5341 | PurchaseCommon Stock | 628,536 | $19.25 | $12,099,318.00 |
DisclosureSEC source: 0001570562-19-000088 · wf-form4_155856672795834.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 923,560 F1 · price: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Dental Innovations BVBA ("DI"). DI holds certain notes issued by ALPHAEON. DI elected to receive payment from ALPHAEON of the outstanding amounts of the notes due in June 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the Dental Innovations BVBA are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F2 · ownership.nature: The reported securities are directly owned by DI and may be deemed beneficially owned by the Reporting Person as a shareholder of DI. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 20:20 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $16.19 | $0.00 |
DisclosureSEC source: 0001570562-19-000022 · wf-form4_154846560188517.xml · derivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 16:27 UTC | Evolus, Inc. EOLS · Entity 5341 | PurchaseCommon Stock | 295,024 | $14.00 | $4,130,336.00 |
DisclosureSEC source: 0001570562-18-000125 · wf-form4_154387242681208.xml · nonDerivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 295,024 F1 · price: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Dental Innovations BVBA ("DI"). DI holds certain notes issued by ALPHAEON. DI elected to receive payment from ALPHAEON of the outstanding principal amounts of the notes due on December 23, 2018 in the form of shares of common stock rather than cash. The shares of common stock received by the Dental Innovations BVBA are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F2 · ownership.nature: The reported securities are directly owned by DI and may be deemed beneficially owned by the Reporting Person as a shareholder of DI. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 13:35 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 9,086 | $0.00 Strike: $8.01 | $0.00 |
DisclosureSEC source: 0001570562-18-000020 · wf-form4_152476413598851.xml · derivative · entry 1 BLANK SIMONE · CIK 0001366840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,086 Underlying: Common Stock · 9,086 shares Expires 2028-04-24 F1 · derivative.exercise_date: The shares subject to the option will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of January 6, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.